1. Home
  2. DNA

DNA

Ginkgo Bioworks Holdings Inc.

Logo Ginkgo Bioworks Holdings Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.

Founded: 2008 Country:
United States
United States
Employees: N/A City: BOSTON
Market Cap: 2.2B IPO Year: N/A
Target Price: $2.20 AVG Volume (30 days): 23.1M
Analyst Decision: Hold Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.46 EPS Growth: N/A
52 Week Low/High: $0.99 - $2.54 Next Earning Date: 05-08-2024
Revenue: $251,455,000 Revenue Growth: -47.36%
Revenue Growth (this year): -10.21% Revenue Growth (next year): 38.77%

Share on Social Networks: